产品详情 |
Edit |   |
Product Name | Recombinant Human CD300c/LMIR2 Fc Chimera Protein, CF |
Description | Purity >90%, by SDS-PAGE under reducing conditions and visualized by silver stain. MW (observed): 60-70 kDa, reducing conditions. MW (theoretical): 43.5 kDa (monomer). The Recombinant Human CD300c/LMIR2 Fc Chimera Protein from R&D Systems is derived from NS0. The Recombinant Human CD300c/LMIR2 Fc Chimera Protein has been validated for the following applications: Bioactivity. |
Size | 50 ug |
Concentration | n/a |
Applications | Bioactivity |
Other Names | CD300c, CD300c antigenCMRF35 antigen, CD300c molecule, CLM6, CLM-6, CMRF-35, CMRF35 leukocyte immunoglobulin-like receptor, CMRF-35A, CMRF35A leukocyte immunoglobulin-like receptor, CMRF35ACMRF35A1, CMRF35CMRF35-A1, CMRF35-like molecule 6, DIgR1, IgSF16, IGSF16CD300 antigen-like family member C, IGSF7, Immunoglobulin superfamily member 16, LIR, LMIR2, MAIR-II |
Gene, Accession, CAS # | CD300C, Gene ID: 10871, Accession: Q08708 |
Catalog # | 3256-LM-050 |
Price | |
Order / More Info | Recombinant Human CD300c/LMIR2 Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
Product Specific References | n/a |
产品资料 |
|
|